WNS (Holdings) Limited (NYSE: WNS), is a leading Business Process Management (BPM) company. We combine our deep industry knowledge with technology and analytics expertise to co-create innovative, digital-led transformational solutions with clients across 10 industries. We enable businesses in Travel, Insurance, Banking and Financial Services, Manufacturing, Retail and Consumer Packaged Goods, Shipping and Logistics, Healthcare, and Utilities to re-imagine their digital future and transform their outcomes with operational excellence.
We deliver an entire spectrum of BPM services in finance and accounting, procurement, customer interaction services and human resources leveraging collaborative models that are tailored to address the unique business challenges of each client. We co-create and execute the future vision of 400+ clients with the help of our 44,000+ employees. Our global footprint spans 16 countries with 61 delivery centers worldwide including in China, Costa Rica, India, the Philippines, Poland, Romania, South Africa, Spain, Sri Lanka, Turkey, United Kingdom and the United States.
To support Global Pharma Franchise (Immuno-Inflammation\Derma\CVM) Commercial strategy team for various requirements of Competitive Intelligence
Have good understanding of Pharmaceutical business from commercial and clinical development perspective; knowledge of global pharmaceutical environment and challenges enabling to provide CI support for early, near to launch and launched medicines
Hand-on experience on secondary data sources and propriety databases such as PharmaProjects, TrialTrove, Cortellis, PharmaTell, Decision Resources, etc.
To manage multiple CI projects under tight timelines interfacing with global clientele and prioritize requests based on the criticality and business need as agreed with the stakeholders
Gain business context about the internal assets, competitor dynamics and monitor competitor activity for a range of KITs/KIQs specific to the medicine/TA
Deliver in depth, comprehensive, regular CI reports and support ad hoc queries in the areas of indication based pipeline landscapes, competitor company/ asset profile, competitor launch timelines and key event timelines, newsletters etc.
To engage with various internal and external stakeholders such as Forecasting/Market intelligence/Pricing & Market access/ Market research / Medical teams and able to stick the various intelligence and report the same
Responsible for continuous process improvement in developing content for various CI deliverables across indications/therapy areas
Interact as a “partner” with onshore stakeholders, not waiting to be asked to give an opinion and pushing back with respect to scenarios, iterations, analysis, and recommendations
Demonstrate excellence as an individual contributor with minimal support from peers/team lead, together with the ability to mentor a team of CI offshore analysts, driving high productivity/ efficiency, and creating appropriate performance reviews and capability development plans
Strong written and oral communication/presentation skills
Experience of leading a small team
Expert in usage of CI desktop tools
Ph.D./ M. Pharm./ Life Science degree
Shift Timings - 12 PM TO 9 PM